Ohio State chemists synthesize possible new anti-tumor agent

May 01, 2001

COLUMBUS, Ohio - Using a frothy brew of soil bacteria as a guide, chemists at Ohio State University have synthesized a substance that may lead to a new generation of chemotherapy drugs.

Laboratories around the world have struggled to create a synthetic version of the chemical, called azinomycin A, ever since it was discovered in bacteria in 1986. The natural form of the chemical breaks down too quickly for scientists to test whether it could be used to combat cancer cells in the body.

Now that Ohio State researchers have completed their quest to build an exact copy of azinomycin A atom by atom, they can try to redesign the chemical into a stable, medically usable form, said Rob Coleman, professor of chemistry at Ohio State and principal investigator of the project.

This research, which was funded by the National Cancer Institute, appears in the current issue of the German chemistry journal Angewandte Chemie. The journal issue, dated May 5, 2001, is set to appear on the World Wide Web at on May 2, 2001, at http://www.angewandte.com.

"More important than synthesizing the agent is what we've learned along the way," Coleman said. "We need to understand the chemical mechanisms behind azinomycin A so that we can develop more effective anti-tumor agents in the future."

Coleman said an enhanced version of azinomycin A might make an especially potent chemotherapy agent. He pointed to laboratory tests from 1987, when Japanese scientists found that the short-lived natural version of the chemical attacked tumor cells in a test tube and was effective as combating cancer in animal models.

Scientists now believe azinomycin A and its sibling azinomycin B -- both produced by a type of Streptomyces soil bacteria - attack DNA by forming very strong bonds, and are two of only a handful of chemicals that bond to DNA in this way.

In 1989, Coleman first began to design the chemical steps needed to synthesize azinomycin A and B in the laboratory. He started the work at the University of South Carolina and, beginning in 1996, at Ohio State.

Over that time, several researchers contributed to the project. In particular, Coleman credits Andrew Carpenter and Thomas Richardson, both his former Ph.D. students, and Jian-She Kong, an Ohio State postdoctoral researcher in chemistry, with performing important preliminary studies. The Ohio State work in the Angewandte Chemie paper was done by Coleman's co-authors, Jing Li and Antonio Navarro, both postdoctoral researchers.

Coleman and his colleagues devised a strategy for breaking the complex-shaped azinomycin A molecule into five smaller pieces. Over 11 years, the researchers performed essentially all possible series of chemical reactions these constituents could undergo, starting over whenever they reached a chemical dead end.

The researchers charted each chemical reaction like a composer would write a score for a symphony orchestra, Coleman said: "We had to write every note for every instrument, think about how the different instruments would play off each other."

To obtain natural azinomycin A for comparison, they fermented a broth of Streptomyces bacteria, which Coleman says resembles a good Irish ale, and isolated both of the azinomycins.

In February 2001, the researchers obtained the synthetic form of azinomycin A that perfectly matched the original. "For all intents and pur

poses, they are absolutely indistinguishable," Coleman said. Now the Ohio State researchers are investigating how azinomycin A and B form such strong bonds with DNA. They have also started tinkering with the synthetic formula.

"We think we're beginning to see why the natural form is unstable, and that gives us some idea of where to go next with building new anti-tumor agents," Coleman said.
-end-
Written by Pam Frost Gorder, 614-292-9475;
Gorder.1@osu.edu

Ohio State University

Related Bacteria Articles from Brightsurf:

Siblings can also differ from one another in bacteria
A research team from the University of Tübingen and the German Center for Infection Research (DZIF) is investigating how pathogens influence the immune response of their host with genetic variation.

How bacteria fertilize soya
Soya and clover have their very own fertiliser factories in their roots, where bacteria manufacture ammonium, which is crucial for plant growth.

Bacteria might help other bacteria to tolerate antibiotics better
A new paper by the Dynamical Systems Biology lab at UPF shows that the response by bacteria to antibiotics may depend on other species of bacteria they live with, in such a way that some bacteria may make others more tolerant to antibiotics.

Two-faced bacteria
The gut microbiome, which is a collection of numerous beneficial bacteria species, is key to our overall well-being and good health.

Microcensus in bacteria
Bacillus subtilis can determine proportions of different groups within a mixed population.

Right beneath the skin we all have the same bacteria
In the dermis skin layer, the same bacteria are found across age and gender.

Bacteria must be 'stressed out' to divide
Bacterial cell division is controlled by both enzymatic activity and mechanical forces, which work together to control its timing and location, a new study from EPFL finds.

How bees live with bacteria
More than 90 percent of all bee species are not organized in colonies, but fight their way through life alone.

The bacteria building your baby
Australian researchers have laid to rest a longstanding controversy: is the womb sterile?

Hopping bacteria
Scientists have long known that key models of bacterial movement in real-world conditions are flawed.

Read More: Bacteria News and Bacteria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.